Trijardy XR 1000 mg/1

Trijardy XR 1000 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for oral use. This extended-release tablet is designed to support glucose control in adults with type 2 diabetes. Learn about its uses, effects, and precautions here.

Trijardy XR 1000 mg/1 is a combination medication used to manage type 2 diabetes. It works by improving blood sugar control through multiple mechanisms. Empagliflozin helps the kidneys remove excess glucose, linagliptin enhances insulin production, and metformin reduces glucose production in the liver. This medication is typically prescribed for adults who require combination therapy to achieve optimal glycemic control.

Common effects of Trijardy XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience urinary tract infections or hypoglycemia, especially when combined with other diabetes medications. It is important to monitor blood sugar levels regularly and consult a healthcare provider if any adverse effects are experienced.

Trijardy XR 1000 mg/1 should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature and kept out of reach of children. Patients with a history of kidney problems, pancreatitis, or lactic acidosis should discuss their medical history with their healthcare provider before starting this medication.

Trijardy XR 1000 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and medications that affect kidney function. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.